T. Rowe Price Health Care ETF (TMED)
NASDAQ: TMED · Real-Time Price · USD
27.66
-0.85 (-2.98%)
Mar 27, 2026, 4:00 PM EDT - Market closed
-2.98% (1D)
| Assets | $17.97M |
| Expense Ratio | 0.44% |
| PE Ratio | 25.94 |
| Shares Out | 650,000 |
| Dividend (ttm) | $0.16 |
| Dividend Yield | 0.58% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 15.16% |
| Volume | 1,572 |
| Open | 28.08 |
| Previous Close | 28.51 |
| Day's Range | 27.66 - 28.08 |
| 52-Week Low | 23.46 |
| 52-Week High | 31.19 |
| Beta | n/a |
| Holdings | 109 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 20.1m in AUM and 102 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
44.63% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.34% |
| UnitedHealth Group Incorporated | UNH | 6.58% |
| Thermo Fisher Scientific Inc. | TMO | 4.50% |
| Gilead Sciences, Inc. | GILD | 4.07% |
| Abbott Laboratories | ABT | 4.05% |
| Danaher Corporation | DHR | 2.70% |
| Medtronic plc | MDT | 2.30% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.08% |
| Stryker Corporation | SYK | 2.06% |
| Dyne Therapeutics, Inc. | DYN | 1.95% |
Performance
News
T. Rowe Price Expands ETF Lineup With 3 Actively Managed Sector Picks Across Key Sectors
In a world where passive investing tends to dominate the headlines, T. Rowe Price is gambling on an alternative formula: sector-focused active management, and at lower costs.
10 months ago - Benzinga
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...
10 months ago - PRNewsWire